Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2025-12-24 @ 4:44 PM
NCT ID:
NCT05468866
Eligibility Criteria:
Inclusion Criteria:
* approval to sign an informed written consent
* patient with newly diagnosed ITP
* platelet count of peripheral blood \< 100×109/ L on at least two consecutive routine blood tests, normal or increased megakaryocyte count in bone marrow (as previously diagnosed)
* no other disease or condition related to thrombocytopenia
* patient age \> 1 year and \< 65 years
Exclusion Criteria:
* Refusal to sign an informed written consent
* Patients with other autoimmune or hemorrhagic diseases (e.g., SLE, severe anemia), or thrombocytopenia due to pregnancy, viruses (e.g., hepatitis C virus, human immunodeficiency virus)
* active infections
* vaccinations, or drugs (e.g., heparin) .
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
65 Years
Study:
NCT05468866
Study Brief:
Protocol Section:
NCT05468866